Royal Bank of Canada - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Royal Bank of Canada on September 21, 2011. The report serves to incorporate by reference the issuance of various Senior Global Medium-Term Notes, Series E, pursuant to the Bank's shelf registration statement on Form F-3 (File No. 333-171806).
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or liquidity ratios. Instead, it details the principal amounts of specific debt securities issued on September 21, 2011:
- Yield Optimization Notes (Pfizer Inc.): $8,856,673.65
- Yield Optimization Notes (Ford Motor Company): $21,677,161.68
- Reverse Convertible Notes: $3,870,000
- Trigger Phoenix Autocallable Securities (IBM): $1,413,500
- Trigger Phoenix Autocallable Securities (Exxon Mobil): $9,348,610
Total principal amount of notes detailed in this filing: approximately $45.17 million.
Material Changes
The filing does not report material changes to the Bank's overall financial condition or operations compared to prior periods. It specifically reports the execution of new debt instruments linked to the equity performance of specific reference stocks.
Guidance, Outlook, and Risks
The document contains no management commentary, forward-looking guidance, or specific risk factors beyond the inherent nature of the structured notes issued. The notes are linked to the common stock of Pfizer Inc., Ford Motor Company, International Business Machines Corporation, and Exxon Mobil Corporation, implying exposure to the volatility of these underlying equities.
Investor Verification Checklist
- Verify the terms and maturity dates of the specific structured notes issued (due September 20, 2012, or September 21, 2012).
- Confirm the total aggregate principal amount of debt issued under the Form F-3 shelf registration.
- Review the legal opinions filed as Exhibits 5.1 and 5.2 regarding the validity of the notes under Canadian and New York law.
- Check subsequent filings for any updates or superseding information regarding these securities.